← Leaderboards
Nadia N Laack
Mayo Clinic Rochester
$4,554,228
Attributed
$5,381,887
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $971.7K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,381,887 · 2
By mechanism
U01$3,726,569 · 1
R01$1,655,318 · 1
Top collaborators
- Debra H Brinkmann6 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Daniel J. Tschumperlin$19,462,790
- Debra H Brinkmann$827,659
- Cheryl A Conover$8,047,873
- Kejal Kantarci$37,462,455
- Matthew Philip Goetz$7,082,692
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsRadiation TherapyDoseBrainMagnetic Resonance ImagingAdultRadiationPrimary Brain NeoplasmsPediatric PatientsBaseChildhoodLeadCurative TreatmentsDementiaComputerizedAlzheimer&AposCranial IrradiationChildBrain RegionBrain NeoplasmsAffinityBrain VolumeAnimal ModelCephalic
Grant awards (13)
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$287,216
U01 · FY2025 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$287,215
U01 · FY2025 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$370,218
U01 · FY2024 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$771,678
U01 · FY2023 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$971,719
U01 · FY2022 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$285,860
U01 · FY2020 · CA · contact PI
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy$752,663
U01 · FY2019 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$265,368
R01 · FY2018 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$310,750
R01 · FY2017 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$316,308
R01 · FY2016 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$106,606
R01 · FY2015 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$319,731
R01 · FY2014 · CA · contact PI
Impact of 18F-FDOPA-PET on neurosurgery and radiotherapy of glioma patients$336,555
R01 · FY2013 · CA · contact PI